Biotech

All Articles

Lilly, Haya ink $1B biobuck obesity deal to explore black genome

.Eli Lilly's search for obesity intendeds has actually led it to the black genome. The Big Pharma ha...

ArsenalBio increases $325M, turns off of former lead possession

.Collection Biosciences is moving on up. The cell therapy firm has actually added $325 thousand in a...

Lilly- backed fat loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' marijuana usage medication flunks period 2b, steering Indivior to rethink $100M option

.Aelis Farma's chances of protecting a fast, beneficial selection on a $one hundred million choice p...

ProKidney stops phase 3 trial certainly not needed to have for tissue therapy authorization

.ProKidney has actually ceased some of a set of phase 3 tests for its cell treatment for renal ailme...

Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer

.Vaxcyte revealed what analysts called "impressive" stage 1/2 records for its 31-valent pneumococcal...

Recursion's brain disease test shows little evidence of effectiveness

.Recursion has discovered by means of a very early examination of its tech-enabled strategy to drug ...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Phone it a case of really good chemical make up: Acepodia, a biotech based upon Nobel Prize-winning...

Praxis epilepsy medication lessens seizures in phase 2 trial

.Practice Accuracy Medicines has scored one more midphase win in epilepsy this year, with its sodium...

Three officers surrender as Dyne posts mixed information for DMD prospect

.After getting away a medical hold numerous years back, Dyne Therapy has actually shown new phase 1/...